Boditech Med Balance Sheet Health
Financial Health criteria checks 6/6
Boditech Med has a total shareholder equity of ₩200.3B and total debt of ₩6.7B, which brings its debt-to-equity ratio to 3.3%. Its total assets and total liabilities are ₩231.1B and ₩30.8B respectively. Boditech Med's EBIT is ₩29.3B making its interest coverage ratio -66.8. It has cash and short-term investments of ₩66.6B.
Key information
3.3%
Debt to equity ratio
₩6.68b
Debt
Interest coverage ratio | -66.8x |
Cash | ₩66.62b |
Equity | ₩200.30b |
Total liabilities | ₩30.79b |
Total assets | ₩231.09b |
Recent financial health updates
Recent updates
Investor Optimism Abounds Boditech Med Inc. (KOSDAQ:206640) But Growth Is Lacking
Jul 12Boditech Med Inc. (KOSDAQ:206640) Shares Fly 49% But Investors Aren't Buying For Growth
Apr 16Here's Why I Think Boditech Med (KOSDAQ:206640) Might Deserve Your Attention Today
Apr 13Could The Market Be Wrong About Boditech Med Inc. (KOSDAQ:206640) Given Its Attractive Financial Prospects?
Mar 01Boditech Med (KOSDAQ:206640) Seems To Use Debt Rather Sparingly
Jan 18Here's Why I Think Boditech Med (KOSDAQ:206640) Is An Interesting Stock
Dec 28Did Business Growth Power Boditech Med's (KOSDAQ:206640) Share Price Gain of 193%?
Dec 08Boditech Med Inc. (KOSDAQ:206640) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Nov 18Financial Position Analysis
Short Term Liabilities: A206640's short term assets (₩133.1B) exceed its short term liabilities (₩27.8B).
Long Term Liabilities: A206640's short term assets (₩133.1B) exceed its long term liabilities (₩3.0B).
Debt to Equity History and Analysis
Debt Level: A206640 has more cash than its total debt.
Reducing Debt: A206640's debt to equity ratio has reduced from 32.4% to 3.3% over the past 5 years.
Debt Coverage: A206640's debt is well covered by operating cash flow (476.1%).
Interest Coverage: A206640 earns more interest than it pays, so coverage of interest payments is not a concern.